Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder (Project1)
An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years
Sponsor: National Institute of Mental Health (NIMH)
This PHASE4 trial investigates Attention Deficit Disorder With Hyperactivity and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Jul 2017 [monthly]
Completed PHASE4
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .